Giatgen A. Spinas
Giatgen A. Spinas
Unknown affiliation
Verified email at usz.ch
Title
Cited by
Cited by
Year
Basal insulin and cardiovascular and other outcomes in dysglycemia
ORIGIN Trial Investigators
New England Journal of Medicine 367 (4), 319-328, 2012
15572012
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
K Maedler, P Sergeev, F Ris, J Oberholzer, HI Joller-Jemelka, GA Spinas, ...
The Journal of clinical investigation 110 (6), 851-860, 2002
13812002
Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function
K Maedler, GA Spinas, D Dyntar, W Moritz, N Kaiser, MY Donath
Diabetes 50 (1), 69-76, 2001
6592001
Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic β-cell turnover and function
K Maedler, J Oberholzer, P Bucher, GA Spinas, MY Donath
Diabetes 52 (3), 726-733, 2003
6062003
The CORE Diabetes Model: projecting long-term clinical outcomes, costs and costeffectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and …
AJ Palmer, S Roze, WJ Valentine, ME Minshall, V Foos, FM Lurati, ...
Current medical research and opinion 20 (sup1), S5-S26, 2004
5002004
Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets
K Maedler, GA Spinas, R Lehmann, P Sergeev, M Weber, A Fontana, ...
diabetes 50 (8), 1683-1690, 2001
4822001
Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial
I Aeberli, PA Gerber, M Hochuli, S Kohler, SR Haile, I Gouni-Berthold, ...
The American journal of clinical nutrition 94 (2), 479-485, 2011
3142011
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
S Kumar, AJM Boulton, H Beck-Nielsen, F Berthezene, M Muggeo, ...
Diabetologia 39 (6), 701-709, 1996
3141996
Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families
P Concannon, HA Erlich, C Julier, G Morahan, J Nerup, F Pociot, JA Todd, ...
Diabetes 54 (10), 2995-3001, 2005
2982005
Validation of the CORE Diabetes Model against epidemiological and clinical studies
AJ Palmera, S Rozea, WJ Valentinea, ME Minshallb, V Foosa, FM Luratia, ...
Current Medical Research and Opinion 20 (sup1), S27-S40, 2004
2982004
“European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses
D P Mikhailidis, M Elisaf, M Rizzo, K Berneis, B Griffin, A Zambon, ...
Current vascular pharmacology 9 (5), 533-571, 2011
2732011
Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.
GA Spinas, U Keller, M Brockhaus
The Journal of clinical investigation 90 (2), 533-536, 1992
2711992
Superiority of small islets in human islet transplantation
R Lehmann, RA Zuellig, P Kugelmeier, PB Baenninger, W Moritz, ...
Diabetes 56 (3), 594-603, 2007
2702007
Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes
D Dyntar, M Eppenberger-Eberhardt, K Maedler, M Pruschy, ...
Diabetes 50 (9), 2105-2113, 2001
2532001
Impact of physical activity on cardiovascular risk factors in IDDM
R Lehmann, V Kaplan, R Bingisser, KE Bloch, GA Spinas
Diabetes care 20 (10), 1603-1611, 1997
2261997
Serum cystatin C is sensitive to small changes in thyroid function
P Wiesli, B Schwegler, GA Spinas, C Schmid
Clinica Chimica Acta 338 (1-2), 87-90, 2003
2052003
Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes.
P Panina-Bordignon, R Lang, PM van Endert, E Benazzi, AM Felix, ...
The Journal of experimental medicine 181 (5), 1923-1927, 1995
1961995
Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM
R Lehmann, A Vokac, K Niedermann, K Agosti, GA Spinas
Diabetologia 38 (11), 1313-1319, 1995
1801995
FLIP switches Fas-mediated glucose signaling in human pancreatic β cells from apoptosis to cell replication
K Maedler, A Fontana, F Ris, P Sergeev, C Toso, J Oberholzer, ...
Proceedings of the National Academy of Sciences 99 (12), 8236-8241, 2002
1772002
Glucose-and interleukin-1β-induced β-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea …
K Maedler, J Størling, J Sturis, RA Zuellig, GA Spinas, POG Arkhammar, ...
Diabetes 53 (7), 1706-1713, 2004
1762004
The system can't perform the operation now. Try again later.
Articles 1–20